Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway.

Nature communications | Aug 6, 2012

http://www.ncbi.nlm.nih.gov/pubmed/22864569

Fbw7 is a ubiquitin-ligase that targets several oncoproteins for proteolysis, but the full range of Fbw7 substrates is not known. Here we show that by performing quantitative proteomics combined with degron motif searches, we effectively screened for a more complete set of Fbw7 targets. We identify 89 putative Fbw7 substrates, including several disease-associated proteins. The transcription factor NF-κB2 (p100/p52) is one of the candidate Fbw7 substrates. We show that Fbw7 interacts with p100 via a conserved degron and that it promotes degradation of p100 in a GSK3β phosphorylation-dependent manner. Fbw7 inactivation increases p100 levels, which in the presence of NF-κB pathway stimuli, leads to increased p52 levels and activity. Accordingly, the apoptotic threshold can be increased by loss of Fbw7 in a p100-dependent manner. In conclusion, Fbw7-mediated destruction of p100 is a regulatory component restricting the response to NF-κB2 pathway stimulation.

Pubmed ID: 22864569 RIS Download

Mesh terms: Cell Cycle Proteins | Cell Line | Cell Line, Tumor | Computational Biology | F-Box Proteins | Glycogen Synthase Kinase 3 | Humans | Immunoblotting | Immunoprecipitation | NF-kappa B p52 Subunit | Phosphorylation | Proteomics | Signal Transduction | Tandem Mass Spectrometry | Ubiquitin-Protein Ligases

Research resources used in this publication

None found

Research tools detected in this publication

Data used in this publication

None found

Associated grants

  • Agency: Cancer Research UK, Id: 12918
  • Agency: Cancer Research UK, Id: A12918
  • Agency: NCI NIH HHS, Id: R01 CA116616
  • Agency: Cancer Research UK, Id:

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.